Cargando…

Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations

Dicarbonyl stress is a dysfunctional state consisting in the abnormal accumulation of reactive α-oxaldehydes leading to increased protein modification. In cells, post-translational changes can also occur through S-glutathionylation, a highly conserved oxidative post-translational modification consis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antognelli, Cinzia, Perrelli, Andrea, Armeni, Tatiana, Nicola Talesa, Vincenzo, Retta, Saverio Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071005/ https://www.ncbi.nlm.nih.gov/pubmed/32024152 http://dx.doi.org/10.3390/antiox9020124

Ejemplares similares

KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced S-Glutathionylation of Distinct Structural and Regulatory Proteins
por: Cianfruglia, Laura, et al.
Publicado: (2019)

KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease
por: Antognelli, Cinzia, et al.
Publicado: (2018)

Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM)
por: Benedetti, Valerio, et al.
Publicado: (2022)

Data in support of sustained upregulation of adaptive redox homeostasis mechanisms caused by KRIT1 loss-of-function
por: Antognelli, Cinzia, et al.
Publicado: (2017)

Multifunctional Platinum@BSA–Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation
por: De Luca, Elisa, et al.
Publicado: (2018)

Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease
por: Perrelli, Andrea, et al.
Publicado: (2023)

Glutathionyl Hemoglobin and Its Emerging Role as a Clinical Biomarker of Chronic Oxidative Stress
por: Scirè, Andrea, et al.
Publicado: (2023)

Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin
por: Retta, Saverio Francesco, et al.
Publicado: (2016)

Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events
por: Bianconi, Andrea, et al.
Publicado: (2022)

Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease
por: Kar, Souvik, et al.
Publicado: (2023)

Vitamin D Deficiency and the Risk of Cerebrovascular Disease
por: Kim, Hyun Ah, et al.
Publicado: (2020)

Defective autophagy is a key feature of cerebral cavernous malformations
por: Marchi, Saverio, et al.
Publicado: (2015)

Glyoxalases in Urological Malignancies
por: Antognelli, Cinzia, et al.
Publicado: (2018)

Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies
por: Marchi, Saverio, et al.
Publicado: (2016)

A Novel Role for Brain Natriuretic Peptide: Inhibition of IL-1β Secretion via Downregulation of NF-kB/Erk 1/2 and NALP3/ASC/Caspase-1 Activation in Human THP-1 Monocyte
por: Mezzasoma, Letizia, et al.
Publicado: (2017)

The Glyoxalase System Is a Novel Cargo of Amniotic Fluid Stem-Cell-Derived Extracellular Vesicles
por: Romani, Rita, et al.
Publicado: (2022)

Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases
por: Perrelli, Andrea, et al.
Publicado: (2018)

Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1
por: Choquet, Hélène, et al.
Publicado: (2016)

Interplay among Oxidative Stress, Methylglyoxal Pathway and S-Glutathionylation
por: de Bari, Lidia, et al.
Publicado: (2020)

Glyoxalase 1−419C>A Variant Is Associated with Oxidative Stress: Implications in Prostate Cancer Progression
por: Antognelli, Cinzia, et al.
Publicado: (2013)

The cerebral cavernous malformations proteins
por: Li, Xiaofeng, et al.
Publicado: (2015)

A Spinal Cavernous Malformation in Multiple Cerebral Cavernous Venous Malformations Syndrome
por: Vangrinsven, Guillaume, et al.
Publicado: (2023)

TNF-α Regulates Natriuretic Peptides and Aquaporins in Human Bronchial Epithelial Cells BEAS-2B
por: Mezzasoma, Letizia, et al.
Publicado: (2013)

Advances in the biology of cerebral cavernous malformations
por: Kivelev, Juri, et al.
Publicado: (2010)

Advances in the biology of cerebral cavernous malformations
por: Hauptman, Jason S., et al.
Publicado: (2010)

Unusual Presentation of Cerebral Cavernous Malformation
por: Kim, Won-Hyung, et al.
Publicado: (2015)

Postzygotic mosaicism in cerebral cavernous malformation
por: Rath, Matthias, et al.
Publicado: (2020)

Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases
por: Antognelli, Cinzia, et al.
Publicado: (2021)

Glyoxalase-1-Dependent Methylglyoxal Depletion Sustains PD-L1 Expression in Metastatic Prostate Cancer Cells: A Novel Mechanism in Cancer Immunosurveillance Escape and a Potential Novel Target to Overcome PD-L1 Blockade Resistance
por: Antognelli, Cinzia, et al.
Publicado: (2021)

CCM3 and cerebral cavernous malformation disease
por: Wang, Kang, et al.
Publicado: (2019)

Recent advances in cerebral cavernous malformation research
por: Padarti, Akhil, et al.
Publicado: (2018)

Pregnancy Combined with Epilepsy and Cerebral Cavernous Malformation
por: Xu, Ya-Lan, et al.
Publicado: (2017)

Gamma Knife radiosurgery for cerebral cavernous malformation
por: Lee, Cheng-Chia, et al.
Publicado: (2019)

Cerebral Cavernous Malformations: The Importance of Cutaneous Manifestations
por: Vázquez-Osorio, Igor, et al.
Publicado: (2021)

Cervical Cord Hemorrhage in Cerebral Cavernous Malformations
por: Wang, Zhanjun, et al.
Publicado: (2021)

Tailored Treatment Options for Cerebral Cavernous Malformations
por: Hoffman, Jessa E., et al.
Publicado: (2022)

Cerebral Cavernous Malformation: Immune and Inflammatory Perspectives
por: Tu, Tianqi, et al.
Publicado: (2022)

Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations
por: Globisch, Maria Ascencion, et al.
Publicado: (2022)

Role of pericytes in the development of cerebral cavernous malformations
por: Dai, Zifeng, et al.
Publicado: (2022)

Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation
por: Globisch, Maria A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ms0t64u5t11jshefr2trpsdf5a